Panelists:

Hannah Chang, MD, PhD, Managing Director - Platanus Ventures

Nick Pliam, MD, PhD, Venture Partner - Decheng Capital

Firas Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI/Glaucoma Consultants of Long Island

Jeffry Weinhuff, Managing Partner - Visionary Venture Fund

Moderated by:

Jonathan Norris, Managing Director - HSBC Innovation Banking

Panelists:

Josh Chiwata, Director, US Business Development and Venture Management - Santen Ventures

Doug Faunce, PhD, Executive Director, Head of Search and Evaluation for Eye Care - AbbVie Ventures

Jonathan Liu, PhD, MBA, Senior Director of Business Development - Topcon Ventures

Murielle Thinard McLane, MBA, Director - Intuitive Ventures

Moderated by:

Babak Nemati, PhD, President & CEO - Strategic Intelligence

Panelists:

Frank Bowden, III, MD, Founder - Bowden Eye & Associates

Paul Karpecki, OD, FAAO, Director, Cornea & External Disease - KEI / Associate Professor - KYCO / Chief Medical Editor - Review of Optometry

Lisa Nijm, MD, JD, Founder & Medical Director / Clinical Assistant Professor of Ophthalmology - Warrenville EyeCare & LASIK in Warrenville, Illinois / Illinois Eye and Ear Infirmary

Leslie O'Dell, OD, FAAO - TFOS Global Ambassador US

Moderated by:

Cecelia Koetting, OD, FAAO, University of Colorado School of Medicine

Panelists:

Tomas Navratil, PhD, Chief Development Officer – Glaukos

Robert N. Weinreb, MD, Chair and Distinguished Professor, Ophthalmology Director - Shiley Eye Institute

Barbara Wirostko, MD, FARVO, CMO & Co-Founder - Qlaris Bio / Co-founder & Medical Advisor - MyEyes / Clinical Adjunct Professor - University of Utah, Moran Eye Center

Moderated by:

Adrienne Graves, PhD, Former CEO - Santen / Board of Directors, Nicox, Ocular Therapeutix, NVasc, Opus Genetics, Surface Ophthalmics, JelliSee, Implandata, Qlaris

Panelists:

Paul Bresge, CEO - Ray Therapeutics

Aziz Mottiwala, Chief Commercial Officer - Tarsus Pharmaceuticals

Todd Pinkney, Chief Commercial Officer - Centricity Vision

Cari Stone, Senior Vice President, Marketing - Elios Vision

Adam Szaronos, President & CEO - Trukera Medical

Moderated by:

Beth Marsh, Vice President, North America Sales and Marketing, Ophthalmology - Apellis Pharmaceuticals

Ocular Therapeutix | Christopher White, Chief Business Officer
Re-Vana Therapeutics | Patrick Ruane, PhD, Chief Operating Officer
Neurotech Pharmaceuticals | Rich Small, CEO
OcuTerra Therapeutics | Kerrie Brady, President & CEO
Annexon Biosciences | Douglas Love, President & CEO
Stealth Biotherapeutics | Reenie McCarthey, CEO
Opus Genetics | Ben Yerxa, PhD, CEO
Ray Therapeutics | Peter Francis, MD, PhD, Chief Medical & Scientific Officer
InGel Therapeutics | Pierre Dromel, PhD, Founder & CEO
Nanoscope Therapeutics | Jared Stephens, VP, Strategy & Business Development

Panelists:
Victor Chong, MD, Vice President and Global Head of Retina - J&J Innovative Medicine

Peter Francis, MD, PhD, Chief Medical & Scientific Officer - Ray Therapeutics

Claire Gelfman, PhD, Chief Scientific Officer - Foundation Fighting Blindness

Maryam Mokhtarzadeh, MD, Senior Director, Regulatory Strategy - REGENXBIO

Charles Semba, MD, Chief Medical Officer - Eluminex Bio

Moderated By:
Theresa Heah, MD, MBA, CEO - Intergalactic Therapeutics

Panelists:

David Esposito, President & CEO - ONL Therapeutics

James Murray, Managing Partner - ExSight Ventures

Eric Schlumpf, President & CEO - Stuart Therapeutics

Riad Sherif, MD, CEO - Oculis

Moderated by:

Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI/Glaucoma Consultants of Long Island

Panelists:

Robert B. Bhisitkul, MD, PhD, Professor of Ophthalmology - University of California San Francisco School of Medicine

Alan J. Franklin, MD, PhD, CEO - ForwardVue Pharma / Ophthalmologist, Vitreoretinal Diseases and Surgery

Paul Karpecki, OD, FAAO, Director, Cornea & External Disease - KEI / Associate Professor - KYCO / Chief Medical Editor - Review of Optometry

Moderated by:

Firas Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

Participants:

Anupam Dalal, MD, Chief Investment Officer and Managing Member - Acuta Capital Partners

Rael Mazansky, MD, MBA, Managing Director – Deep Track Capital

Annabel Samimy, Managing Director, Biopharmaceuticals - Stifel Financial Corp.

Cameron Taylor, Managing Director - BofA Securities | Life Sciences

Moderated by:

Pravin Dugel, MD

Panelists:

Mark L. Baum, Founder, CEO & Chairman of the Board - Harrow

Tomas Navratil, PhD, Chief Development Officer - Glaukos

Andrew Stewart, President, Global Pharmaceuticals and International Consumer - Bausch + Lomb

Moderated by:

William J. Link, PhD, Managing Partner - Flying L Partners